Results 281 to 290 of about 85,660 (309)
Some of the next articles are maybe not open access.
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
2011
Primary cutaneous lymphomas are rare, accounting for 2% of all lymphomas. About 75% are T-cell lymphomas. There are two major subgroups within the cutaneous T-cell lymphomas (CTCL) spectrum: mycosis fungoides (MF) and Sezary syndrome (SS). MF is the prototype of CTCL. It is defined as a peripheral, epidermotropic non-Hodgkin’s T-cell lymphoma
openaire +1 more source
Primary cutaneous lymphomas are rare, accounting for 2% of all lymphomas. About 75% are T-cell lymphomas. There are two major subgroups within the cutaneous T-cell lymphomas (CTCL) spectrum: mycosis fungoides (MF) and Sezary syndrome (SS). MF is the prototype of CTCL. It is defined as a peripheral, epidermotropic non-Hodgkin’s T-cell lymphoma
openaire +1 more source
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Ca-A Cancer Journal for Clinicians, 2020Enrica Marchi
exaly
Zosteriform cutaneous T-cell lymphoma
Journal of the American Academy of Dermatology, 1995R M, Ricci +3 more
openaire +2 more sources
Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma
Ca-A Cancer Journal for Clinicians, 2010Julie M Vose
exaly
Hodgkin lymphoma: A review and update on recent progress
Ca-A Cancer Journal for Clinicians, 2018Satish P Shanbhag, Richard F Ambinder
exaly
2016 US lymphoid malignancy statistics by World Health Organization subtypes
Ca-A Cancer Journal for Clinicians, 2016Lauren R Teras +2 more
exaly